English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Pulmonary Fibrosis Foundation announced research results from four studies examining access to care and outcomes for patients living with pulmonary fibrosis and interstitial lung disease.
Tag: Respiratory Disease
Cellular Quality-Control System Identified as a Culprit in Coronavirus Infection
The unfolded protein response plays a key role in how Middle East Respiratory Syndrome damages the lungs. MERS is much less common but much lethal than COVID-19, which is also caused by a coronavirus.
Focus on “Growing Stronger” for Pulmonary Fibrosis Awareness Month in September
September is Pulmonary Fibrosis Awareness Month, presented by the Pulmonary Fibrosis Foundation (PFF) as a way to drive awareness of pulmonary fibrosis (PF), a debilitating, incurable lung disease. Learn more about the numerous endeavors intended to rejuvenate the fight against PF throughout September.
Rutgers Engineers Developing Rapid Breathalyzer Test for COVID-19
New Brunswick, N.J. (April 30, 2021) – Rutgers University–New Brunswick engineering professors Edward P. DeMauro, German Drazer, Hao Lin and Mehdi Javanmard are available for interviews on their work to develop a new type of fast-acting COVID-19 sensor that detects the presence…
Young survivors of acute myeloid leukemia have long-term complications from treatment
Adolescent and young adult (AYA) patients treated for acute myeloid leukemia (AML) have a high risk of developing several long-term health complications after treatment, a study led by UC Davis Comprehensive Cancer Center researchers has found. The most common complications were cardiovascular, endocrine and respiratory diseases. The complications – known as late effects – were more present among non-white AYA patients and those living in more deprived neighborhoods.
Cover Clinical Trials Session, June 24, Before ATS 2020 Virtual Kick-Off
ATS 2020 Virtual is taking place on Aug. 5-10, but you can register for “Breaking News: Clinical Trial Results in Pulmonary Medicine,” a preview session taking place on June 24 at 2-3:45 pm ET. Review program details here. Please note that all content for the Clinical Trial Results session is embargoed until 2 p.m. ET June 24.
Evidence suggests previously unrecognized latex allergies may play role in equine asthma
DENVER/December 16, 2019 – Latex exposure could be detrimental to a horse’s respiratory health. That’s the surprising discovery from Morris Animal Foundation -funded research at the Royal Agricultural University and University of Nottingham. While further investigation is needed, researchers say…
Evidence suggests previously unrecognized latex allergies may play role in equine asthma
DENVER/December 16, 2019 – Latex exposure could be detrimental to a horse’s respiratory health. That’s the surprising discovery from Morris Animal Foundation -funded research at the Royal Agricultural University and University of Nottingham. While further investigation is needed, researchers say…